Near-term applications include combinations with kinase inhibitors (KIs)that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location ...
This latest news for Windtree’s cardiovascular pipeline makes a total of 58 patents issued or allowed, with 17 pending. The cardiovascular patent estate includes istaroxime, the dual mechanism SERCA2a ...
Judge Chapman, an American Lawyer Lifetime Achievement honoree, worked on many of the largest and most impactful bankruptcies ...
Merck will acquire Cidara Therapeutics for $9.2B to expand its respiratory portfolio, driven by demand for CD388 as ...
Merck Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the ...
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ('Adial” or the 'Company”), a clinical-stage biopharmaceutical company focused on ...
Avicanna Inc. ("Avicanna" or "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization ...
Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...
Near-term – Closing and funding of the Quazar Investment of $50 million.
NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...
PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback